Dina Amrom1, Demet Kinay2, Yvonne Hart2, Samuel F Berkovic2, Ken Laxer2, Frederick Andermann2, Eva Andermann2, Amit Bar-Or1. 1. From the Neurogenetics Unit (D.A., E.A.), Epilepsy Clinic (F.A.), and Neuroimmunology Unit (A.B.-O.), Montreal Neurological Hospital and Institute, Quebec, Canada; Departments of Neurology & Neurosurgery (D.A., F.A., E.A., A.B.-O.), Pediatrics (F.A.), and Human Genetics (E.A.), McGill University, Montreal, Quebec, Canada; Okmeydani Education and Research Hospital (D.K.), Istanbul, Turkey; Royal Victoria Infirmary (Y.H.), Newcastle-upon-Tyne, UK; Epilepsy Research Center (S.F.B.), Department of Medicine (Neurology), University of Melbourne, Australia; and Department of Neurology (K.L.), University of California at San Francisco. amit.bar-or@mcgill.ca dina.amrom@mcgill.ca. 2. From the Neurogenetics Unit (D.A., E.A.), Epilepsy Clinic (F.A.), and Neuroimmunology Unit (A.B.-O.), Montreal Neurological Hospital and Institute, Quebec, Canada; Departments of Neurology & Neurosurgery (D.A., F.A., E.A., A.B.-O.), Pediatrics (F.A.), and Human Genetics (E.A.), McGill University, Montreal, Quebec, Canada; Okmeydani Education and Research Hospital (D.K.), Istanbul, Turkey; Royal Victoria Infirmary (Y.H.), Newcastle-upon-Tyne, UK; Epilepsy Research Center (S.F.B.), Department of Medicine (Neurology), University of Melbourne, Australia; and Department of Neurology (K.L.), University of California at San Francisco.
Abstract
OBJECTIVE: To describe a potential association between comorbid autoimmune disease and Rasmussen encephalitis (RE) and discuss potential insights into underlying RE pathogenesis. METHODS: We report a case series of 4 patients with RE in whom a comorbid autoimmune disease was subsequently diagnosed and review the literature on possible common susceptibility factors. RESULTS: In 4 patients who presented with typical clinical features of RE, a comorbid autoimmune disease was subsequently diagnosed: Hashimoto thyroiditis, ulcerative colitis, Crohn disease, and systemic lupus erythematosus. We discuss the possible common predisposing factors. CONCLUSIONS: The association of RE, a rare entity, with a comorbid autoimmune disease raises the possibility of shared mechanisms of susceptibility, including common immunogenetic and/or environmental risk factors.
OBJECTIVE: To describe a potential association between comorbid autoimmune disease and Rasmussen encephalitis (RE) and discuss potential insights into underlying RE pathogenesis. METHODS: We report a case series of 4 patients with RE in whom a comorbid autoimmune disease was subsequently diagnosed and review the literature on possible common susceptibility factors. RESULTS: In 4 patients who presented with typical clinical features of RE, a comorbid autoimmune disease was subsequently diagnosed: Hashimoto thyroiditis, ulcerative colitis, Crohn disease, and systemic lupus erythematosus. We discuss the possible common predisposing factors. CONCLUSIONS: The association of RE, a rare entity, with a comorbid autoimmune disease raises the possibility of shared mechanisms of susceptibility, including common immunogenetic and/or environmental risk factors.
Authors: Y Li; A Uccelli; K D Laxer; M C Jeong; H V Vinters; W W Tourtellotte; S L Hauser; J R Oksenberg Journal: J Immunol Date: 1997-02-01 Impact factor: 5.422
Authors: Nicholas Schwab; Christian G Bien; Anne Waschbisch; Albert Becker; Giles H Vince; Klaus Dornmair; Heinz Wiendl Journal: Brain Date: 2009-01-29 Impact factor: 13.501
Authors: S W Rogers; P I Andrews; L C Gahring; T Whisenand; K Cauley; B Crain; T E Hughes; S F Heinemann; J O McNamara Journal: Science Date: 1994-07-29 Impact factor: 47.728
Authors: Geoffrey C Owens; My N Huynh; Julia W Chang; David L McArthur; Michelle J Hickey; Harry V Vinters; Gary W Mathern; Carol A Kruse Journal: J Neuroinflammation Date: 2013-05-02 Impact factor: 8.322
Authors: Sugandha Dandekar; Hemani Wijesuriya; Tim Geiger; David Hamm; Gary W Mathern; Geoffrey C Owens Journal: Front Immunol Date: 2016-12-19 Impact factor: 7.561
Authors: Geoffrey C Owens; Alejandro J Garcia; Aaron Y Mochizuki; Julia W Chang; Samuel D Reyes; Noriko Salamon; Robert M Prins; Gary W Mathern; Aria Fallah Journal: Front Immunol Date: 2019-01-29 Impact factor: 7.561